Contact Us
Schwab Client Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Spravato

Recent news which mentions Spravato

Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
Tickers JNJ NEWS
Tags Psychedeclis for TDR premium ketamine depression
From Benzinga
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Tickers ABBV AMGN CURLF JAZZ
Tags MNMD Esketamine Market News
From Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
Tickers JNJ
Tags Markets Psychedelics Earnings
From Benzinga
Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year
Tickers JNJ
Tags contributors Ketamine Cannabis
From Benzinga
Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion
Tickers DELCF NAD
Tags DELCF Management NAD+ infusion therapy
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.